New drug combo aims to boost immune system against prostate cancer
Disease control
Recruiting now
This study is testing whether adding immunotherapy drugs to standard radiation and hormone therapy can better control high-risk prostate cancer that is still confined to the prostate area. It will enroll 64 men to see if the drug combination helps lower PSA levels more effectivel…
Phase: PHASE2 • Sponsor: Zin W Myint • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC